Zim Laboratories Limited - Asset Resilience Ratio

Latest as of September 2025: 0.24%

Zim Laboratories Limited (ZIMLAB) has an Asset Resilience Ratio of 0.24% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs11.07 Million

≈ $119.67K USD Cash + Short-term Investments

Total Assets

Rs4.70 Billion

≈ $50.84 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Zim Laboratories Limited's Asset Resilience Ratio has changed over time. See Zim Laboratories Limited (ZIMLAB) flexibility index to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down Zim Laboratories Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Zim Laboratories Limited market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs11.07 Million	0.24%
Total Liquid Assets	Rs11.07 Million	0.24%

Asset Resilience Insights

Limited Liquidity: Zim Laboratories Limited maintains only 0.24% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zim Laboratories Limited Industry Peers by Asset Resilience Ratio

Compare Zim Laboratories Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Zim Laboratories Limited (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Zim Laboratories Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.02%	Rs900.00K ≈ $9.73K	Rs4.72 Billion ≈ $51.05 Million	+0.01pp
2024-03-31	0.01%	Rs403.00K ≈ $4.36K	Rs4.47 Billion ≈ $48.32 Million	0.00pp
2023-03-31	0.01%	Rs453.00K ≈ $4.90K	Rs3.42 Billion ≈ $36.94 Million	-0.37pp
2022-03-31	0.38%	Rs12.95 Million ≈ $140.00K	Rs3.42 Billion ≈ $36.95 Million	-4.78pp
2021-03-31	5.16%	Rs167.65 Million ≈ $1.81 Million	Rs3.25 Billion ≈ $35.12 Million	+4.64pp
2020-03-31	0.53%	Rs17.09 Million ≈ $184.85K	Rs3.25 Billion ≈ $35.18 Million	+2.39pp
2019-03-31	-1.86%	Rs-61.18 Million ≈ $-661.66K	Rs3.28 Billion ≈ $35.52 Million	-0.61pp
2018-03-31	-1.25%	Rs-37.34 Million ≈ $-403.83K	Rs2.98 Billion ≈ $32.26 Million	-1.25pp
2017-03-31	0.00%	Rs1.00K ≈ $10.81	Rs2.59 Billion ≈ $28.02 Million	+0.18pp
2016-03-31	-0.18%	Rs-4.56 Million ≈ $-49.36K	Rs2.56 Billion ≈ $27.70 Million	--

pp = percentage points

About Zim Laboratories Limited

NSE:ZIMLAB India Drug Manufacturers - Specialty & Generic

Market Cap

$58.62 Million

Rs5.42 Billion INR

Market Cap Rank

#21260 Global

#1171 in India

Share Price

Rs111.23

Change (1 day)

-1.56%

52-Week Range

Rs60.26 - Rs127.87

All Time High

Rs149.00